Genetic polymorphism and cancer risk.

被引：37

作者：

Clapper M.L. ^{[1
]}

机构：

[1] Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, 19111, PA

来源：

Current Oncology Reports | 2000年 / 2卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Cancer Risk; Breast Cancer Risk; Cancer Susceptibility; Oral Squamous Cell Carcinoma; Lung Cancer Risk;

D O I：

10.1007/s11912-000-0075-z

中图分类号：

学科分类号：

摘要：

Inter-individual variability in carcinogen metabolism has been attributed in part to the polymorphic expression of several phase I and II detoxification enzymes. The role of these genetic polymorphisms in cancer susceptibility has been most extensively evaluated for isozymes of cytochrome P450 (CYP1A1, CYP2D6, and CYP2E1), N-acetyltransferase (NAT1 and NAT2), glutathione S-transferase (GSTM1, GSTT1, and GSTP1), microsomal epoxide hydrolase, and NAD(P)H:quinone oxidoreductase. Our understanding of the genetic basis of cancer risk has been enhanced most recently by establishment of genotype-phenotype correlations in humans and identification of numerous diverse factors, both genetic and environmental, that can modify risk.

引用

页码：251 / 256

页数：5

共 115 条

[21]

Stampfer MJ(1994)Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants Hum Mol Genet 3 421-428

[22]

Hough HL(1999)Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer Br J Cancer 79 168-171

[23]

Katoh T(1998)Association between lung cancer and microsomal epoxide hydrolase genotypes Cancer Res 58 5291-5293

[24]

Kaneko S(1998)Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility Recent Results Cancer Res 154 47-85

[25]

Boissy R(1997)Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase) Br J Cancer 75 69-75

[26]

Moisio ML(1999)609 C to T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Lett 135 67-71

[27]

Sistonen P(1999)GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels Eur J Cancer Prev 8 315-323

[28]

Mecklin JP(1997)Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk Carcinogenesis 19 1285-1289

[29]

Heinimann K(1998)Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide Cancer Epidemiol Biomarkers Prev 7 703-709

[30]

Scott RJ(1998)Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers Cancer Epidemiol Biomarkers Prev 7 823-829

← 1 2 3 4 5 6 7 8 9 10 →